ArticleFrontiers in neurology2025
Baseline ASPECTS predicts early neurological deterioration and functional outcomes after endovascular thrombectomy in acute ischemic stroke.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of Short-Course Methylprednisolone Therapy With Early Composite Imaging Abnormalities in Patients With Early Neurological Deterioration After Endovascular Thrombectomy for Acute Ischemic Stroke.Revista de neurologia · 2026Article
- Endovascular thrombectomy in patients with acute ischemic stroke and prestroke mRS 3: a multicenter IPTW analysis focused on functional preservation.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early neurological deterioration (END), defined as neurological decline after endovascular thrombectomy (EVT) for acute ischemic stroke (AIS), is a critical complication associated with poor long-term prognosis. Although END significantly impacts clinical outcomes, its underlying mechanisms and modifiable risk factors remain poorly understood. This study aimed to (1) characterize the clinical profile of END and (2) evaluate its association with 90-day functional outcomes in AIS patients who underwent EVT. Methods: This retrospective study included consecutive patients with acute ischemic stroke (AIS) secondary to large vessel occlusion (LVO) who were treated with endovascular thrombectomy (EVT) between January 2021 and December 2024. END was defined as either a ≥4-point increase in the National Institutes of Health Stroke Scale (NIHSS) score or a ≥1-point increase in the NIHSS consciousness subscore (Item Ia) within 72 h after EVT. Patients meeting these criteria were classified into the END group; others comprised the non-END group. Variables with a Results: The study included 177 consecutive AIS patients with LVO who were treated with EVT. END occurred in 52 patients (29.4%). The END group had significantly lower baseline ASPECTS values than the non-END group (median [IQR]: 7 [6-8] vs. 9 [8-9], Conclusion: END after EVT independently predicts poor 90-day functional independence (mRS 0-2) in LVO-related AIS. Our findings support incorporating a baseline ASPECTS ≤7 into risk stratification protocols to identify high-risk patients requiring intensive neuromonitoring (hourly NIHSS assessments for 72 h post-EVT). Early detection of END signs, such as a ≥ 4-point increase in the NIHSS score 4, may enable prompt interventions (e.g., blood pressure control or edema management) to improve long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.